Unique features of the transcriptional response to model aneuploidy in human cells by Dürrbaum, M. et al.
Dürrbaum et al. BMC Genomics 2014, 15:139
http://www.biomedcentral.com/1471-2164/15/139RESEARCH ARTICLE Open AccessUnique features of the transcriptional response to
model aneuploidy in human cells
Milena Dürrbaum1,3, Anastasia Yurievna Kuznetsova1, Verena Passerini1, Silvia Stingele1, Gabriele Stoehr2,4
and Zuzana Storchová1,3*Abstract
Background: Aneuploidy, a karyotype deviating from multiples of a haploid chromosome set, affects the
physiology of eukaryotes. In humans, aneuploidy is linked to pathological defects such as developmental
abnormalities, mental retardation or cancer, but the underlying mechanisms remain elusive. There are many
different types and origins of aneuploidy, but whether there is a uniform cellular response to aneuploidy in
human cells has not been addressed so far.
Results: Here we evaluate the transcription profiles of eleven trisomic and tetrasomic cell lines and two cell
lines with complex aneuploid karyotypes. We identify a characteristic aneuploidy response pattern defined by
upregulation of genes linked to endoplasmic reticulum, Golgi apparatus and lysosomes, and downregulation of
DNA replication, transcription as well as ribosomes. Strikingly, complex aneuploidy elicits the same transcriptional
changes as trisomy. To uncover the triggers of the response, we compared the profiles with transcription changes
in human cells subjected to stress conditions. Interestingly, we found an overlap only with the response to
treatment with the autophagy inhibitor bafilomycin A1. Finally, we identified 23 genes whose expression is
significantly altered in all aneuploids and which may thus serve as aneuploidy markers.
Conclusions: Our analysis shows that despite the variability in chromosome content, aneuploidy triggers uniform
transcriptional response in human cells. A common response independent of the type of aneuploidy might be
exploited as a novel target for cancer therapy. Moreover, the potential aneuploidy markers identified in our analysis
might represent novel biomarkers to assess the malignant potential of a tumor.Background
Aneuploidy, or a change in cellular chromosome numbers,
has profound effects on the physiology of all eukaryotic
cells analyzed to date [1]. Aneuploid yeasts are character-
ized by slow growth, altered sensitivity to various stresses
and increased genomic instability [2-4]. At the same time,
aneuploidy drives genetic variability and cellular adap-
tation capacity in yeast [5,6]. Plants are in general more
tolerant to gene dosage changes, yet aneuploidy often
impairs their vigour and alters their phenotype [7]. An-
euploid mammals are rarely viable and the sporadic
survivors are affected on multiple levels. In humans,
aneuploidy is responsible for a substantial proportion* Correspondence: storchov@biochem.mpg.de
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article, unless otherwise stated.of spontaneous abortions and the rare survivors with
trisomy of chromosome 13, 18 and 21 (Patau, Edward and
Down syndrome, respectively) are severely handicapped;
only trisomy 21 is compatible with survival until adult-
hood [8]. Aneuploidy is also linked to cancer, as nearly
90% of solid tumors and 75% of hematopoietic cancers
show abnormal chromosome dosage [9]. Recently it has
been shown that the occurrence of aneuploid cells in-
creases with aging [10] and an increased incidence of
aneuploidy in the brain has been linked to neurodegen-
erative diseases [11].
The exact mechanisms underlying the detrimental
effects of aneuploidy remain unclear, but it has been
convincingly shown that they are caused by the expression
of the extra genes on the supernumerary chromosome [3].
In most aneuploid cells the chromosome dosage changes
lead to correlating changes in mRNA (e.g. [3,12-15]) as
well as on protein levels [6,15,16]. These analyses furthertral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
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and proteins originating from the aneuploid chromosome,
the expression of multiple other genes is altered as well
[3,13,15,17]. This is likely a consequence of two different
phenomena. First, an increase in gene copy number of a
transcription factor or other regulatory factor might affect
transcription levels of genes on other chromosomes [18].
Second, specific pathways might be activated in a cellular
response to aneuploidy. Recent attempts to uncover the
consequences of aneuploidy suggest that aneuploidy indeed
instigates a specific response in eukaryotic cells [3,15,19].
Haploid yeast strains carrying an additional chromosome
(hereafter referred to as disomes) exhibit a common tran-
scriptional signature that has been previously identified in
budding yeast as a so called environmental stress response
that is triggered upon various exogenous stresses, such as
oxidative stress, heat shock or slow growth [3,20]. A similar
response was identified in a study comparing transcriptome
data from disomic and complex aneuploid strains of
budding yeast, partial aneuploids of fission yeast, aneu-
ploid Arabidopsis thaliana plant cells, mouse cell lines
with Robertsonian translocations that lead to trisomies,
and human cells from patients with trisomy syndromes
[19]. Additionally, comparative transcriptomics and prote-
omics of model human trisomic and tetrasomic cells
identified a common pattern in the transcriptional response
to aneuploidy [15]. These studies pointed out similarities in
the response to aneuploidy in most eukaryotes. At the same
time, the results showed that the response in mammalian
cells diverges from the response in other model organisms,
because the correlation of the transcription changes in
aneuploid mammalian cells with transcriptional changes
in other aneuploid species is rather modest [19]. More-
over, as there is no equivalent of the environmental stress
response identified so far in mammalian cells, it remains
unclear what triggers the transcriptional changes.
To obtain a comprehensive insight into the changes
specific for human cells, we evaluated in detail multiple
tri- and tetrasomic cell lines as well as model complex
aneuploid human cell lines with hypotetraploid karyo-
types more similar to cancer cells. Remarkably, we found
that the cellular responses to complex multichromoso-
mal aneuploidy and trisomy or tetrasomy of one single
chromosome closely correlate. As the identified pathway
pattern resembles the cellular stress response, we com-
pared the aneuploidy response to the transcriptional
changes in human cells subjected to various stress con-
ditions. Additionally, we have also identified 18 genes
that were upregulated and 5 genes downregulated in all
analyzed aneuploid cell lines and might thus serve as
markers of aneuploidy. This is the first study which
compares a variety of different human cell lines with
aneuploidy of different types and origins. By uncovering
a uniform aneuploidy response pattern our results outlinethe cellular consequences of an abnormal karyotype in
human cells.
Results
Common cellular response to trisomy and tetrasomy in
human cell lines
Recently, we established de novo human aneuploid cell
lines that were derived from diploid and chromosomally
stable cells by a micronuclei-mediated chromosome trans-
fer [15]. We performed transcriptional analysis of the
original diploid cell lines and their trisomic and tetrasomic
derivatives (HCT116: trisomy of chromosome 3 – 3/3;
tetrasomy of chromosome 5 - 5/4; RPE1: trisomy of chro-
mosome 5 and 12 - 5/3 12/3, trisomy of chromosome
21 - 21/3, see Methods for further details) and calculated
the aneuploid-to-diploid fold change for all detected
mRNAs. Similarly, we calculated the relative aneuploid-
to-diploid ratio to determine the transcriptional changes
in trisomic human cells lines generated from the diploid
colorectal adenocarcinoma cell line DLD1 by introduction
of an extra copy of chromosome 3, 7 or 13 [13]. To
identify the similarities and differences among the
transcriptional profiles of the model aneuploid cell
lines in response to aneuploidy, we used an algorithm
called 2-dimensional annotation analysis that quantifies
the relative up- and downregulation of cellular pathways.
Hereby, abundance changes of all factors assigned to
each pathway are compared to the overall abundance
distribution and relative values are calculated [21]. Add-
itionally, significantly up- and downregulated pathways
were validated by the annotation enrichment tool DAVID,
which employs a different algorithm for the analysis (data
not shown) [22]. As expected, pathways altered and
enriched in the 2-dimensional annotation analysis were
also identified as enriched by DAVID in all cell lines.
Our analysis identified a specific pattern of pathways
that are altered in all compared model trisomic and tetra-
somic cell lines (Table 1). Among the most upregulated
categories we identified the endoplasmic reticulum (ER),
Golgi apparatus, lysosomes and vacuoles, membrane
metabolism and the MHC protein complex and anti-
gen processing. In contrast, DNA and RNA metabolic
pathways – e.g. DNA replication, repair, transcription or
RNA splicing - were significantly downregulated (Figure 1A,
Additional file 1: Figure S1A). Remarkably, although similar
pathways are up- and downregulated in all aneuploid cell
lines, we noticed that the specific factors that significantly
contribute to the differentiated regulation are variable.
For example, the members of the proton oligopeptide
cotransporter family SCL15 (Gene Ontology Cellular
Component “membrane, lysosome, lytic vacuole”) show
variable expression levels in the analyzed aneuploid cell
lines: SLC15A3 is upregulated in all of the HCT116 de-
rived aneuploid cell lines, but not in the RPE1 derived
Table 1 Pathway classes recurrently and significantly altered in aneuploid cell lines
Replication Transcription Ribosome Golgi ER Lysosomes Membrane
metabolism
Vacuole Mitochondria Spliceosome MHC class
proteins
HCT116 5/4 - - - + + + + + - - +
HCT116 3/3 - - - + + + + + - -
HCT116 5/4* - - - + + + (+) + - / +
HPT1 - - + - + + + + / - +
HPT2 - - - + + + + + + - +
RPE1 12/3
5/3
- - + + + + + + + + +
RPE1 21/3* - - - + + + + + - - +
DLD1 3/3 - - - + / / + + - - /
DLD1 7/3 - - / / / / / + / - /
DLD1 13/3 - - - + / / + + - - /
HE35 8/3_1 +/− - - - - / / +/− / + + /
HE35 8/3_2 - - - + + / +/− / +/− + +
HE35 8/3_3 - −/+ - + + + +/− + (+) + /
Asterisks indicate the cell lines expressing H2B-GFP.
/ = annotation not significantly altered.
+= annotation category upregulated.
- = annotation category downregulated.
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only in HCT116 H2B-GFP 5/4 and SLC15A1 is upregu-
lated in three out of seven aneuploid cell lines derived
from HCT116 and RPE1 (Additional file 2: Table S1).
Interestingly, DLD1 with trisomy of chromosome 7
shows only partial overlap with the other aneuploid cell
lines: pathways related to splicing and to DNA and RNA
metabolism were similarly downregulated, and vacuole
was upregulated, whereas additional changes in the tran-
scription profile differed from the other trisomic and
tetrasomic cell lines (Additional file 1: Figure S1B, Table 1).
We also determined the response to aneuploidy in three
clones with trisomy of chromosome 8 (here labeled as
HE35 8/3_1, 2, and 3) derived from human primary
embryonic fibroblasts HE35 by microcell-mediated chro-
mosome transfer [17]. Using the 2-D annotation analysis
algorithm, we observed similar changes in pathway regu-
lations in the HE35-derived trisomies as in the other
tri- and tetrasomic cell lines (Figure 1B, Additional file 1:
Figure S1C, Table 1). Taken together, the results indicate
that all the analyzed human cells with de novo created
trisomies and tetrasomies elicit a nearly identical pattern
of pathway changes regardless of the identity of the super-
numerary chromosome and the cell line.
Complex aneuploidy triggers the same pathway changes
as low-complexity aneuploidy
Next, we asked whether similar pattern of changes in
gene expression could be observed in cells with complex
aneuploidy. This type of karyotypic changes might more
closely resemble the situation observed in tumors thatoften harbor multiple changes in chromosome numbers
and structures, including deletions, translocations and
amplifications [23]. To this end, we used cell lines derived
from HCT116 that underwent a transient tetraploidy
induced by cytokinesis failure (Figure 2A). As tetraploidy
leads to catastrophic mitosis and chromosomal instability,
the majority of cells die soon after the tetraploidization
[9,24], and the chromosome numbers of the few survivors
are remarkably altered (Figure 2B). We analyzed the tran-
scriptional changes identified in two clonal survivors,
cell lines HPT1 and HPT2, by calculating the fold
change of the transcripts in comparison to the original
HCT116. This first global analysis of the transcriptional
response in human cells with model complex aneuploidy
reproduced the pattern of pathway changes observed in
the tri- and tetrasomic cell lines (Figure 2C,D, Additional
file 1: Figure S1D, E, Table 1, Additional file 3). Im-
portantly, the duration of the cell cycle of the complex
aneuploid cell lines is indistinguishable from diploids
(Additional file 1: Figure S2). Previously, it has been
proposed that the transcriptional changes identified in
aneuploid cells are caused by the slow growth, which is
typical for model trisomic cell lines [3,14,15]. Thus,
our finding indicates that the response to aneuploidy
in mammalian cells is not always associated with a
slower progression through the cell cycle, and thereby
the slower proliferation cannot be the only cause of
the identified transcriptional changes.
Distance matrix of the Spearman rank correlation of
all analyzed cell lines confirmed the high similarity
among the transcriptional changes triggered by aneuploidy
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Figure 1 Pathway alterations in tri- and tetrasomic cell lines.
A. 2-dimensional pathway analysis comparison of HCT116 with
tetrasomy of chromosome 5 and DLD1 with trisomy of chromosome
13. Each dot represents an annotation as defined by GO and KEGG
databases, color-coding marks related annotations as stated in the
inset legend. The label “Others” indicates annotations that were not
generalized in larger categories (see Methods). Examples of
specific pathways categorized by the color- code are annotated.
B. 2-dimensional pathway analysis comparison of HE35 (clone 2)
with trisomy of chromosome 8 and RPE* with trisomy of
chromosome 21. Asterisks indicate the cell lines with H2B-GFP.
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http://www.biomedcentral.com/1471-2164/15/139(Figure 2E). We call the identified common pattern of
transcriptional changes the Aneuploidy Response Pattern
(ARP). Our results demonstrate that trisomy can serve as
a valuable model for analysis of complex aneuploidy.
Moreover, the identification of ARP suggests that chromo-
somal imbalance itself might be exploited as a novel targetfor cancer therapy regardless the type of aneuploidy and
the mechanism by which it was generated.Comparison of the aneuploidy response pattern with
transcriptional responses to stress stimuli
What triggers the specific transcriptional response to
aneuploidy in human cells? Current analysis in budding
yeast suggests that mutations interfering with cell pro-
liferation result in similar gene expression changes as
aneuploidy [19]. Alternatively, the transcription changes
may be triggered by cellular stress caused by the presence
of an extra chromosome. Thus, we asked whether there
are stress stimuli that trigger reprogramming of gene
expression similar to the ARP. To this end, we compared
the transcription profiles of HCT116 cells exposed to
sub-lethal concentrations of hydrogen peroxide, nitric
oxide, hydroxyurea, actinomycin D and bafilomycin A1,
or grown under hypoxic conditions as well as in medium
with either low or high glucose (for further details see
Methods). Strikingly, the majority of the stressors trig-
gered pathway changes that are remarkably different
from the ARP (Figure 3A, Additional file 1: Figure S3).
In contrast, we observed a partial similarity between
the ARP and the transcriptional changes in HCT116
treated with actinomycin D, a polypeptide antibiotic that
inhibits the activity of RNA polymerases (Figure 3B,D).
The 2-D annotation analysis revealed that treatment
with actinomycin results in downregulation of DNA- and
RNA- metabolism as well as in upregulation of ER,
membrane metabolism and lysosome. This might indicate
that the downregulation of DNA- and RNA metabolism
in aneuploid cell lines is due to transcriptional inhibition
and its consequences. However, the overlap includes only
a few genes with a low Spearman correlation coefficient
and thus the distance of the Spearman rank correlation is
higher compared to the distances between the aneuploid
cell lines (Figure 3D). Remarkably, treatment with
bafilomycin A1 that inhibits vacuolar-ATPases showed
transcriptional changes nearly identical to the ARP
(Figure 3C,D). Bafilomycin A1 impairs vesicle fusion
[25] and thus inhibits the final steps of autophagy due
to the failure of autophagosome-lysosome fusion. As
in aneuploids, the transcriptional changes include down-
regulation of DNA and RNA metabolism, whereas mem-
brane associated annotations are upregulated. In contrast,
treatment with bafilomycin does not lead to upregulation
of ER, Golgi or lysosomal pathways (Figure 3C). The simi-
larity with transcriptional effects of autophagy-inhibiting
drug suggests that one of the main consequences of aneu-
ploidy in human cells is the overload of the autophagic
pathway. Taken together, our findings imply that the tran-
scriptional changes in response to aneuploidy differ from










































































































































































































Figure 2 Complex aneuploidy triggers similar pathway changes as trisomy or tetrasomy. A. Schematic depiction of the construction
of aneuploid cell lines with complex karyotype changes. B. Chromosome numbers in clonal cell lines originating from an unstable tetraploid
intermediate. The numbers above the plot indicate the median chromosome number. C. 2-dimensional pathway analysis comparison of the complex
aneuploid cell line HPT1* and HCT116 5/4. D. 2-dimensional comparison of complex aneuploid cell line HPT2* and DLD1 13/3. E. Distance matrix of
the Spearman rank correlation of all analyzed aneuploid cell lines. Large distances present a low correlation and vice versa. The Spearman
distance metric is defined as distanceSpearman = (1- correlationSpearman)/2 in the distanceMatrix function as part of the R Class Discovery
package. The function calculates the distance of the correlation between column vectors, each of which represents different microarray experiments.
Asterisks indicate the cell lines with H2B-GFP.




























































































































































































































Figure 3 Comparison of the Aneuploidy Response Pattern with transcriptional responses to stress stimuli. A. 2-dimensional pathway
analysis comparison of HCT116-derived complex aneuploid cell line HPT1* and HCT116 treated with hydroxyurea. B. 2- dimensional pathway analysis
comparison of HCT116-derived complex aneuploid cell line HPT2* and HCT116 treated with actinomycin D. C. 2-dimensional pathway analysis
comparison of HCT116 with tetrasomy of chromosome 5 and HCT116 grown in medium with bafilomycin A1 D. Distance matrix of the Spearman rank
correlation of aneuploid cell lines and HCT116 grown in stress-inducing conditions. Asterisks indicate the cell lines with H2B-GFP. Abbreviations:
bafilo = bafilomycin; actino = actinomycin; HU = hydroxyurea; NO = nitric oxide; H2O2 = hydrogen peroxide; glc = glucose.
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and transcription.
Markers of aneuploidy
Our results imply the existence of factors with recurrent
expression changes triggered by aneuploidy that might
serve as general markers of aneuploidy in human cells. To
identify genes that are consistently up or downregulatedin aneuploid cells, we merged all available datasets of
aneuploid cell lines created in our laboratory. This
yielded 18 genes whose expression is more than 1.4 fold
increased and 5 genes whose expression is more than
1.4 fold decreased in all analyzed aneuploids (Figure 4,
Table 2). The changes in mRNA levels are consistent
with proteomics measurements in 7 out of 8 proteins for












































































Figure 4 Expression levels of the putative aneuploidy markers. Heatmap of fold change ratios (aneuploid/diploid) of the 18 upregulated and
5 downregulated genes, hierarchical clustering of Euclidean distance. Asterisks indicate the cell lines with H2B-GFP.
Dürrbaum et al. BMC Genomics 2014, 15:139 Page 7 of 14
http://www.biomedcentral.com/1471-2164/15/139expression of only one of these 23 genes (FRY) is similarly
upregulated by the stress stimuli, suggesting that the
recurrent expression changes are indeed in response to
aneuploidy. Using quantitative real-time PCR we validated
the expression levels of four of the identified upregulated
genes in eight aneuploid cell lines and corresponding
diploid controls (RAB27B, COL13A1, HOXB5, GLRX).
This approach confirmed overexpression of all four genes
in response to aneuploidy. Interestingly, none of the tested
transcripts was confirmed in one of the complex aneu-
ploid cell line, HPT1 (Figure 5). These candidate markers
could potentially enable the discrimination of tumors with
low frequency of aneuploid cells from tumors with high
levels of aneuploidy and thus higher malignant potential.
Further experiments will be required to determine
whether the candidate markers can be used for clinical
purposes for example by standard immunohistochemistry.
Discussion
Significant recent progress in the analysis of aneuploidy
in eukaryotes has revealed multiple novel features linked
to aneuploidy such as growth defects, abnormal proteinhomeostasis and increased genomic instability. These fea-
tures appear to be conserved among eukaryotes, an obser-
vation which is further supported by the finding that
the transcriptional response to aneuploidy in different
species remarkably correlates [19]. We analyzed in detail
the transcriptional changes in aneuploid human cells by
comparing the calculated aneuploid-to-diploid ratio. The
comparison of eleven aneuploid model cell lines derived
from four different diploid progenitor cell lines by either
chromosome transfer of seven different chromosomes or
by clonal propagation from unstable tetraploid progenitors
revealed a striking similarity among the cell lines. The
identified signature of pathways that was altered in all
analyzed cell lines, which we term the aneuploidy response
pattern - ARP - is characterized by upregulation of the ER
and Golgi related pathways, lysosome and lytic vacuoles,
MHC protein complex and antigen processing, whereas
DNA and RNA metabolism and ribosome-related path-
ways were always downregulated (Figures 1, 2, Tables 1,
2). Our results reveal that the transcriptional changes to
aneuploidy in human cells are not mediated by a canonical
p53-dependent stress response, because DLD1 and its
Table 2 List of consistently up- and downregulated transcripts (cut off 1.4 fold change)
Gene Chromosome Function Protein
levels
Link to cancer?
1 PLAUR 19 Plasminogen activator, urokinase receptor 4/5 Ovarian and colorectal cancer
2 RAB27B 18 Secretory GTPase 4/4 Breast cancer
3 P4HA2 5 Procollagen-proline 4/6 Metastasis
4 FRY 13 Regulator of actin cytoskeleton 0/3
5 BDKRB1 14 Bradykinine receptor NA Breast and lung cancer
6 HOXB5 17 Transcription factor NA Leukemia, ovarian carcinoma and
others
7 GDF15 19 Growth differentiation factor 1/2 Ovarian and prostate cancer
8 OASL 12 2'-5'-oligoadenylate synthetase-like NA
9 SERPINE2 2 Serpine protease inhibitor 4/4 Metastasis
10 IFI44 1 Interferon-induced protein 44 NA
11 AMDHD1 12 Protein with amidohydrolase domain NA
12 TMEM171 5 Transmembrane protein 171 NA
13 GLRX 5 Glutaredoxin 4/4 Pancreatic cancer
14 TMEM169 2 Transmembrane protein 169 NA
15 DMBT1 10 Membrane glycoprotein NA Multiple cancers
16 COL13A1 10 Collagen type XIII, alpha1 1/1
17 SH2D1B 1 Signal transduction control NA
18 MIA Melanoma inhibitory activity NA Neuronal tumors
1 XYLB 3 Xylulokinase homologue NA
2 LOXL3 2 Lysyl oxidase homologue NA
3 MYB/NFIB
fusion
6 Myb – NFIB fusion NA
4 EEPD 7 Endonuclease/exonuclease/phosphatase domain
containing
NA
5 ARHGEF39 9 Rho guanine nucleotide exchange factor 39 NA
The column “Protein levels” shows how often corresponding changes of the protein levels were identified by Stingele et al. [15] (number of cell lines with altered
protein expression/number of cell lines where the protein was quantified; NA – proteomics data not available). The rows 1-18 show upregulated genes; the rows
1- 5 (below) show downregulated genes.
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feature of the identified transcriptional changes is that
although similar pathways are up- and downregulated
in individual aneuploids, the individual genes whose
expression is altered are often variable among the dif-
ferent cell lines. Furthermore, several pathways were
up- or downregulated in the analyzed cells that were
not recurrent and thus cannot be regarded as a general
consequence of aneuploidy per se. These changes are
probably specific to the type of extra chromosomes as
well as to the clonal selection. We also show for the
first time that the pathway changes in human cells with
complex, hypotetraploid karyotypes correlate with the
changes identified in simple trisomies. Thus, the analysis
of model trisomic cell lines might provide important
insights into the role of the more complex aneuploidy
that is frequently found in cancer.Two of the analyzed cell lines (trisomy 7 in DLD1 and
one of the three clones of trisomy 8 in HE35) showed
only a partial aneuploidy response pattern (Additional
file 1: Figure S1B). There are several possible scenarios
to explain this finding. First, loss of some chromosome
parts or a mosaic aneuploid population could lead to a
weakening of the ARP. However, the transcription levels
of the transcripts coded on the extra chromosomes were
elevated in these cell lines as expected, which excludes
this possibility. Alternatively, features specific to the
supernumerary chromosome can be responsible for the
difference, such as in case of chromosome 7. This has
been previously observed in budding yeast, where some
disomes, e.g. disome of chromosome 1, do not trigger
the environmental stress response pattern (ERS) other-
wise observed in other disomic strains [3]. In support












































































HCT116 HCT116* RPE1 RPE1*
3/3 5/4 5/4 HPT1HPT2 5/312/3 21/3C C C C
HCT116 HCT116* RPE1 RPE1*
3/3 5/4 5/4 HPT1HPT2 5/312/3 21/3C C C C
A B
C D
HCT116 HCT116* RPE1 RPE1*
3/3 5/4 5/4 HPT1HPT2 5/312/3 21/3C C C C
HCT116 HCT116* RPE1 RPE1*
3/3 5/4 5/4 HPT1HPT2 5/312/3 21/3C C C C
Figure 5 Quantitative real-time PCR analysis of putative aneuploidy markers. A. Fold change mRNA expression levels of COL13A1
quantified by real-time PCR. B. Fold change mRNA expression levels of RAB27B. C. Fold change mRNA expression levels of HOXB5. D. Fold change
mRNA expression levels of GLRX. Asterisks indicate the cell lines expressing H2B-GFP.
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gained than lost in chromosomally unstable cancer cells
[26]. Thus, an extra copy of chromosome 7 likely repre-
sents a lesser burden for the cells than most of the
other chromosomes. Finally, the deviation from the ARP
might arise due to a mutation occurring during the clonal
selection after the chromosome transfer. This is likely
the case in HE35 8/3, where two clones correlate stron-
ger with other aneuploids than the third trisomy 8
clone (Figure 2E). Despite these exceptions, our results
show that aneuploidy triggers a uniform transcriptional
response in human cells that is independent of the
identity and quantity of the extra chromosomes and
their combination as well as of the cell line type.
The ARP is characterized by strong downregulation of
DNA and RNA metabolism, which correlates with the
slow growth observed in nearly all aneuploid cells analyzedto date. Indeed, many factors required for DNA replication
are less abundant, such as the heterohexameric replicative
helicase MCM (Additional file 2: Table S1), and this may
partially explain the previously observed slow progression
through the S-phase [15]. However, the complex aneuploid
cell lines progress through interphase at a rate closely
matching the rate of the corresponding diploid cell
lines and yet the levels of factors involved in replication
are similarly decreased (Additional file 1: Figure S2).
Therefore, we conclude that the proliferation impairment
cannot be the only cause of ARP.
DNA repair is significantly downregulated, which might
lead to increased accumulation of DNA damage. The
abundance changes in the DNA replication and repair
factors might explain how aneuploidy increases genome
instability, as has been observed in yeast [4] as well as
in human aneuploids (S.S., V.P., Z.S., unpublished results).
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of the consistent downregulation of DNA metabolism
pathways and what consequences it brings upon aneu-
ploid cells.
Among the most upregulated pathways we observed
the Golgi network, ER related pathways, lysosomes and
lytic vacuoles, membrane metabolism and the MHC
protein complex and antigen processing. The function
of MHC protein complexes is to display fragments of
proteins from within the cell to immune cells [27]. Cur-
rently we do not understand the reasons for the increased
levels of the MHC protein complex transcripts in aneu-
ploid cells. We hypothesize that increased protein expres-
sion and degradation elevates the peptide presentation
by MHC complex, thus elevating the immunogenicity of
aneuploid cells, similarly as it has been recently observed
in murine aneuploid tumors [28]. In the future it will be
important to confirm this observation on the protein level
and to determine whether the MHC proteins are correctly
localized and functional.
Elevated expression of ER related genes might suggest
an expansion of the ER that was shown in budding
yeast to occur in order to alleviate ER stress [29]. This
phenomenon is accompanied by elevated lipid biosyn-
thesis, but unchanged amounts of ER chaperones [29],
which closely resembles the transcriptional changes
observed in aneuploid cell lines. This suggests, together
with the fact that mouse trisomic MEFs are more sensitive
to the Hsp90 inhibitor 17-AAG [30], that aneuploid cells
suffer from protein folding defects, most likely due to the
saturation of the cellular folding capacity [31]. ER stress
is often observed in various cancers, where it is usually
attributed to tumor microenvironments characterized by
hypoxia, nutrient limitation and low pH [32]. It will be
interesting to test whether chromosomal copy number
changes also contribute to the ER stress in cancer cells.
Previously, it was proposed that the transcriptional
response to aneuploidy is indicative of stress and slow
growth [1]. Therefore, we were interested whether
treatment with stress inducing agents will elicit similar
response as the presence of an extra chromosome. Since
chromosome missegregation was shown to trigger oxi-
dative stress [24,33], we analysed the transcriptional
response to oxidative stress inducers nitric oxide and
hydrogen dioxide. Aneuploidy was also recently linked
to DNA damage and replication stress [34], therefore
we analyzed the response to the replication inhibitor
hydroxyurea and transcription inhibition by actinomycin
D. Further, aneuploidy was shown to trigger proteotoxic
stress and to activate autophagy [3,15,30,31]. Therefore,
we compared the response to aneuploidy to the tran-
scriptional changes elicited by cells grown under hypoxic
conditions, which is known to result in energy and ER
stress with subsequent proteotoxic stress. Similarly, wetested the transcriptional changes in cells where au-
tophagy was inhibited, a condition known to trigger
proteotoxic stress. The comparison with transcription
profiles of cells grown on high or low glucose was of
particular interest, because aneuploid cells show changes
in the metabolic pathways and higher energy demands
[3,14,15]. Remarkably, we found that none of the stress
conditions triggers response similar to ARP.
The only significant exception was the striking similarity
between the ARP and the transcriptional changes observed
in cells treated with sub-lethal concentrations of bafilomy-
cin A1 (Figure 3). Treatment with bafilomycin A1 leads to
the accumulation of vesicles and membranes and reduces
cell proliferation. The similarity of cellular response to
inhibition of autophagy and to aneuploidy might suggest
that aneuploidy inhibits autophagy. This however is not
true as we previously documented by an observation that
autophagic flux (the dynamic flow through autophagy) is
in aneuploids as efficient as in diploids [15]. Inhibition
of basal autophagy by bafilomycin A1 treatment causes
proteotoxic stress [35]. Current data suggest that aneu-
ploidy leads to proteotoxic stress as well [31]. We propose
that the similarity between the transcriptional response to
treatment with bafilomycin A1 and the ARP is because
both reflect transcriptional changes in cells suffering from
proteotoxic stress. In general, the effect of bafilomycin A1
further emphasizes the role of autophagy in mammalian
aneuploids. Aneuploidy leads to activation of autophagy
in human and mouse cells [15,30] and aneuploid cells
are more sensitive to the autophagy inhibiting drug
chloroquine [30]. The consistent upregulation of lysosomes
and lytic vacuoles appears to be specific for mammalian
cells as it was not observed in aneuploid yeasts and plants
[19]. In this context it is interesting that there is nearly no
correlation of ARP and transcriptional changes upon low
glucose condition, which is known to trigger autophagy
(Additional file 1: Figure S3). We believe that this is
because autophagy in aneuploids is not activated by energy
or nutrition deprivation, but by different, so far unidenti-
fied triggers [36]. Partial overlap of ARP was also observed
with the response to treatment with the drug actinomycin
D that represses transcription by RNA polymerase and,
among other effects, leads to an imbalance of ribosomal
subunits [37]. Transcription-related pathways are also
downregulated in aneuploids, suggesting the possibility
that some of the phenotypic features of aneuploid cells
might be caused by transcriptional deficiency.
Our work has also allowed the identification of several
genes that were consistently up- or downregulated in an-
euploid cell lines, but not in the HCT116 cells under
stress stimuli. Several of the identified factors have been
previously linked to cancer (Table 2). For example the
plasminogen activator and urokinase receptor PLAUR/
UPAR is frequently overexpressed in ovarian and
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metastatic potential and emerges as a marker of malig-
nancy [38]. P4HA2 is a precursor of collagen and a metas-
tasis marker [39] and HOXB5 is a homeobox
transcription factor whose overexpression has been
found in several malignant tumors [40]. Transcription of
the TGFβ superfamily cytokine GDF15 (growth differenti-
ation factor 15) is increased in multiple solid tumors,
where it promotes tumor growth and confers resist-
ance to several drugs such as bortezomib. Recent studies
proposed GDF15 as a prognostic marker for ovarian and
pancreatic carcinoma [41], two types of malignancies
with frequent aneuploidy and chromosomal instability
[9]. Glutaredoxin (GLRX) protects cells from oxidative
stress and serves as a potential marker of malignancy
in pancreatic carcinoma. Interestingly, some of the fac-
tors such as a xylulokinase homologue (XYLB), the 2′-5′-
oligoadenylate synthetase like (OASL) and the interferon-
induced protein (IFI44) have not been so far linked to can-
cer and may represent markers of aneuploidy that are not
linked to malignancy.
Aneuploidy is associated with poor prognosis and in-
creased drug resistance in tumors [42]. This suggests an
interesting possibility that some of the genes that are
expressed at higher levels in response to aneuploidy
in non-transformed cells may subsequently enhance
the malignant potential of these cells, whereas higher
expression of others might represent a barrier for car-
cinogenesis. The expression of the marker genes, if
confirmed in a wide range of aneuploid cell lines and in
cancer cells, might provide an excellent tool for cancer
biology and treatment, because it may allow distinguish
tumors with high aneuploidy from predominantly diploid
tumors. Moreover, pathways that are activated or inhibited
by aneuploidy may serve as novel targets for cancer
treatment. This has been recently demonstrated by the
fact that aneuploid cells are more sensitive to drugs
inhibiting HSP90, autophagy inhibitors and inhibitors
of the AMPK kinase, which strongly correlates with the
identified increased requirements for autophagy, protein
folding and energy metabolism in aneuploid mammalian
cells ([15,30] and this work). Further research should
elucidate the efficacy of this approach. Our work for the
first time identifies global changes in a broad spectrum of
human aneuploid cell lines and may therefore help to
generate new hypothesis for cancer treatments.
Conclusions
In this study we identified a transcriptional aneuploid re-
sponse pattern (ARP), a set of transcriptional changes,
common in a broad range of human aneuploid model
cell lines. This, for the first time, shows that complex
aneuploidy, which is frequently found in cancer cells,
exhibits the same transcriptional pathway changes assimple trisomy and tetrasomy. A general response to
aneuploidy, as identified here in a variety of aneuploid
model cell lines, might serve as a novel therapeutic
target in cancer treatment. Further, we found 23 genes
consistently deregulated in our model aneuploid cell
lines. A confirmation of these markers in aneuploid
cells might open new strategies for identifying aneu-
ploid tumors. Since the fraction of aneuploid cells in
tumor correlates with malignant potential and poor
prognosis in cancer, simple and reliable biomarkers for
aneuploidy may help for determining the appropriate
cancer therapy.Methods
Cell lines
Following model aneuploid cell lines were used for data
analysis: parental cell line HCT116 (human colon car-
cinoma cell line): HCT116 3/3 (trisomy 3), HCT116 5/4
(tetrasomy 5) [43]; parental cell line HCT116 H2B-GFP:
HCT116 5/4 (tetrasomy 5) [15], HPT1, HPT2 (hyperte-
traploids with complex karyotypes, A.Y.K. unpublished
data); parental cell line RPE1 (human retinal pigment
epithelial cell line, hTERT immortalized): RPE15/3 12/3
(trisomy 5, 12); parental cell line RPE1 H2B-GFP: RPE1
21/3 (trisomy 21) [15]; parental cell line DLD1 (human
colon adenocarcinoma cell line): DLD1 3/3 (trisomy 3),
DLD1 7/3 (trisomy 7), DLD1 13/3 (trisomy 13) [13], par-
ental cell line HE35 (human embryonic cell line): HE35
8/3, clones 1–3 [17].Cell cultures
The HCT116- and RPE1- derived tri- and tetrasomic cell
lines have been described previously [15]. The post- tetra-
ploid cell lines HPT1 and HPT2 were generated by expan-
sion of individual tetraploids formed by induced inhibition
of cytokinesis through dihydrocytochalasin treatment. The
DNA content was determined by flow cytometry, standard
karyotyping, chromosome painting and array comparative
genomic hybridization as in [15]. Cells were maintained
in 10 cm dishes in Dulbecco’s Modified Eagle Medium
(DMEM) at 37°C and 5% CO2. Culture medium was
supplemented with growth factors from 5% Fetal Calf
Serum (FCS) and 1% Penicillin/ Streptavidin to avoid
bacterial growth and contamination. Specific antibiotics
were added to the medium when necessary to maintain
the supernumerary chromosomes. Cell lines were cultured
at 70- 90% confluence for a maximum of 10 passages.
Material for transcription analysis was obtained at
the earliest possible time point, after sufficient amount
of cells was achieved, approximately 25 generations
after the chromosome transfer or tetraploidization, re-
spectively. Similar approach was taken for the analysis
of trisomy 8 HE35-derived clones [17]. The mRNA of
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different passages [13].
Cell growth analysis
Freshly cultured cells that carry H2B-GFP to fluorescently
label the chromosomes were seeded 24 h before the ex-
periment. Time laps movies were taken by imaging
asynchronous cells in a 10 min or 4 min interval for
72 or 48 h, respectively. The time in interphase was
measured as the time from nuclear envelope reformation
to nuclear envelope break down.
Quantitative real-time PCR
Total RNA was extracted with the RNeasy Mini Kit
(Qiagen), treated with DNAse (recombinant DNase, Roche)
and subsequently transcribed into cDNA (Transcriptor
First Strand cDNA Synthesis Kit, Roche Diagnostics).
Specific primers were designed using PrimerBlast; the
sequences are listed below. Quantitative PCR was
conducted using the Light Cycler 480 System (Roche
Diagnostics) with the KAPA SYBR FAST master mix
optimized for Roche Light Cycler 480 (KapaBiosystems).
Absolute quantification with an external standard was
performed and negative non-template controls were
tested in all experiments. The specificity of the primer
product amplification was confirmed in each run by
melting curve analysis. mRNA expression was normalized
to the control gene coding for ribosomal protein L30
(RPL30) and fold change to corresponding diploid mRNA
expression was calculated. Primers: COL13A1 – forward:
GGGGGAAGCAGGACTAGATG, reverse: CCTGAAGCT
CCGGGTAGTC, RAB27B - forward: TGCGGGACAAGA
GCGGTTCCG, reverse: GCCAGTTCCCGAGCTTGCCG
TT, HOXB5 - forward: TCCACAAATCAAGCCCTCCA,
reverse: GTCCGGGCCATTTGGATAAC, GLRX – forward:
AACGGTGCCTCGAGTCTTTA, reverse: CCTATGAGATC
TGTGGTTACTGC.
mRNA expression analysis by microarrays
Genome-wide expression profiling of HCT116- and RPE1-
derived aneuploid cells lines was conducted in three
replicates by IMGM laboratories GmbH (Martinsried,
Germany) as previously described [15]. cDNA was hybrid-
ized on Agilent Whole Human Genome Oligo microarrays
(4x44K format) for HCT116 diploid and HCT116 5/4,
or Agilent SurePrint G3 Human GE microarrays (8x60K)
for the other cell lines according to a One-Color based
hybridization protocol. Raw data was background normal-
ized. The data has been deposited in the NCBI Gene
Expression Omnibus (GEO, http://www.ncbi.nlm.nih.gov/
geo/) accessible through GEO Series accession number
GSE47830 and GSE47836.
Microarray data of trisomic and diploid colorectal can-
cer cell lines DLD1 [13] were kindly provided by ThomasRied (National Institutes of Health, Bethesda, Maryland,
USA). All other mRNA expression data were obtained
from NCBI’s Gene Expression Omnibus (http://www.ncbi.
nlm.nih.gov/geo/). HCT116 cell line grown under high
and low glucose conditions: accession number GSE31084;
HCT116 after stress treatment: accession number GSE3176;
HCT116 cell line treated with actinomycin D: with
GSE12459, human embryonic diploid and trisomic
cells: accession number GSE28076.
Microarray normalization
Bioinformatics analysis of the microarray data was per-
formed using Perseus (1.2.6.16) as part of the MaxQuant
Software Package [21] and R on the free open source
integrated development environment R Studio. The gBG
SubSignal (green Background Subtracted Signal) from
background-normalized cDNA microarray data was used
for further normalization. The background-subtracted raw
intensities were log2 transformed and global normal-
ization of the log transformed raw data was performed by
subtracting the median of the overall signal intensities for
one experiment from each signal in this experiment. Probe
sets for one gene were summarized by taking the median.
The median of replicative probes signal intensities was
calculated for each cell line. For comparison of each
aneuploid cell line with the corresponding diploid cell
line gene, expression fold change ratios were calculated.
Data analysis
The Student’s t-test was performed to verify the statis-
tical significance of the fold change in mRNA expression
between the signal intensities of aneuploid and diploid
cell line. To correct the test statistics for multiple com-
parisons, false discovery rate control of the p-values was
applied. Both local and frequent FDR were calculated
with the “fdrtool” package [44]. For further analysis, a
fold change cut off 1.4 in mRNA expression was applied.
To investigate the correlation between the cell lines, a
distance matrix of the Spearman rank correlation coeffi-
cient was calculated in R using the “ClassDiscovery”
package in the OOMPA library and “mclust” package.
Distance of the correlation was visualized in a colored
matrix in the “spatstat” package. To investigate a global
response to aneuploidy on gene level, data sets were
filtered for those genes more than 1.4 fold up- or down-
regulated in all HCT116 and RPE1 derived cell lines.
The resulting gene lists were analyzed for their function
and relation using the DAVID functional annotation tool
[22], KEGG pathway and the NCBI Gene database.
Pathway enrichment analysis
Pathway enrichment analysis was conducted in Perseus
using the 2-dimensional annotation enrichment tool [21].
Thereby, enriched GO and KEGG annotations were
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egory have a significant preference to be altered com-
pared to the global fold change data distribution.
Significance was tested by a t-test followed by a false
discovery rate correction in the Benjamini-Hochberg
procedure (FDR cut off 0.02). Expression values for sig-
nificant enriched annotations were summarized in an
annotation score from −1 to 1 to represent levels of up-
or downregulation. Significant and enriched annotations
were summarized in larger, general categories for
visualization purposes. 2-dimensional annotations en-
richments of two cell lines were plotted in R. Highly up-
or downregulated pathways were cross validated by sub-
mitting the fold change cut off datasets to the annotation
enrichment tool DAVID [22].
Statistical analysis
Commonly used R packages were “lattice” [45], “genefilter”
[46], “fdrtool” [44] and “calibrate” [47]. In addition, Perseus
(1.2.6.16) as part of the MaxQuant Software Package [21]
was used for microarray analysis. All statistically evaluated
experiments were performed in at least three independent
biological replicates. The final plots were prepared in
GraphPad Prism 5 software or R.
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